FORM OF SERIES A TERM SHEETEN文档格式.docx
《FORM OF SERIES A TERM SHEETEN文档格式.docx》由会员分享,可在线阅读,更多相关《FORM OF SERIES A TERM SHEETEN文档格式.docx(19页珍藏版)》请在冰豆网上搜索。
Amount
US$
intotal
Structure;
Securities
TheInvestorwillpurchasecertainnumberofSeriesAPreferredSharesnewlyissuedbytheCompanythatrepresent
%ofthesharecapitaloftheCompanyonafully-dilutedandas-convertedbasisimmediatelyfollowingtheconsummationofthetransactioncontemplatedhereby.
Valuation
Afully-dilutedpre-moneyvaluationofUS$
(includinganyandallsharesreservedundertheCompany’semployeestockoptionplan)andafully-dilutedpost-moneyvaluationof$
.ThecapitalizationtableoftheCompanyissetforthon
ScheduleII
attachedhereto.
BridgeLoan
LoanAmount
TheInvestorwillpurchasecertainconvertiblepromissorynote(the“Note”)withanaggregateprincipalamountofUS$
.
TermsofNote
ThekeytermsofeachNoteareasfollows:
1.Maturitydate:
monthsaftertheclosingoftheNotefinancing(the“NoteClosing”);
2.Interest:
simpleinterestof
%perannum(zerointerestiftheNoteisconvertedintoSeriesAPreferredShares);
interestincreasedto
%perannumuponoccurrenceofaneventofdefault;
3.Noprepaymentisallowed;
4.Security:
pledgeofnolessthan
%equityinterestheldbytheFoundersintheCompany[andtheDomesticCompany];
FoundersandtheCompanyshallbejointlyandseverallyliablefortheobligationsundertheNote;
5.Conversion:
EachholderoftheNoteshallhavetheright(butnottheobligation)toconvertall(oranypartof)oftheoutstandingprincipalamountoftheNote(and,ifsoelectedbysuchholder,anyinterestaccruedthereon)intoSeriesAPreferredSharesupontheClosingatapershareconversionpriceequalto(i)
%ofthepersharepurchasepricefortheSeriesAPreferredShares(the“PerSharePrice”)iftheClosingisconsummatedwithin
daysoftheNoteClosing,or(ii)
%ofthePerSharePriceiftheClosingisconsummateduponorafterdays
oftheNoteClosing;
6.Customaryeventsofdefaultincludingcustomarycrossdefaultprovisions.
SharesPurchaseAgreement
RepresentationandWarrantie
TheGroupCompaniesandtheFounderswillmakecustomaryrepresentations,warranties,covenantsandindemnificationsonajointandseveralbasis.
Useof
Proceeds
Theproceedswillbeusedfor[productresearchanddevelopment,businessexpansion,andworkingcapital]andotherpurposesasagreedbytheInvestor.
Closing
Conditions
1.EstablishmentofanappropriatelegalandbusinessstructureacceptabletotheInvestorfortheCompany’soperations,including(i)theexecutionofasetofcustomaryControlDocuments(asdefinedbelow)and(ii)thedesignationofanInvestornomineetoholdupto
%equityinterestintheDomesticCompany;
2.Executionoflaborcontract,inventionassignment,confidentiality,non-competeandnon-solicitationagreementbytheFoundersandKeyEmployeesasagreedbytheInvestorwiththeapplicableGroupCompany;
3.ExecutionofdirectorindemnificationagreementbetweentheCompanyandthedirectorappointedbytheInvestor(the“InvestorDirector”);
4.ExecutionofacustomarymanagementrightsletterinfavouroftheInvestor;
5.ApprovaloftransactionbytheInvestor’sinvestmentcommittee;
6.Completionofbusiness,finance,andlegalduediligencebytheInvestoranditsadvisorstotheirsatisfaction;
7.Allnecessaryapprovalsandconsentshavingbeenobtainedfromexistingshareholders,partiesandrelevantgovernmentauthorities;
8.Issuanceofrelevantlegalopinions;
9.Nomaterialadverseeffect;
10.Submissionofadetailedbusinessplanandbudgetforthe[twelvemonths]followingtheClosingwhichisacceptabletotheInvestor;
11.Executionofrelevanttransactiondocuments(includingwithoutlimitationShareholdersAgreement,MemorandumandArticlesandShareRestrictionAgreementetc.)andsatisfactionofconditionsprecedentcontainedtherein;
12.RepresentationsandwarrantiesoftheGroupCompaniesandtheFoundersbeingtrue,accurateandcompleteasoftheClosing;
13.OtherclosingconditionsidentifiedintheInvestors’duediligenceorotherwisegenerallyapplicabletosimilartransactions.
Covenants
TheCompanywillprovideongoingcovenantsto(i)complywiththeUSForeignCorruptPracticesAct,(ii)useofcommerciallyreasonableeffortstoavoidPFICstatusandminimizetheeffectsofCFCandPFICstatustotheextenteitheroccurs,(iii)complywithPRClawinallmaterialrespects,including,without
limitation,SAFECircular37andSAFECircular7,(iv)fileandrgisteranyequitypledgeascontemplatedbythetransactiondocumentswiththecompetentgovernmentalauthorities,and(v)takesuchotheractionsasmayreasonablybedeemednecessarybytheInvestorbasedonitsduediligence.
MemorandumandArticles
Rightsand
Preferences
ofSeriesA
Preferred
Shares
TheSeriesAPreferredSharesshallhavetherightsandpreferencesassetforthin
ScheduleI
heretowhichwillbesetforthintheCompany’smemorandumofassociationandarticlesofassociation.
ShareholdersAgreement
Boardof
Directors
TheBoardofDirectorsoftheCompanyshallconsistof
directors.TheInvestorshallhavetherighttodesignateatleast
directors(and[1]observer).TheboardofdirectorsofanyotherGroupCompanyshallbesimilarlycomposed.
Pre-emptive
RightstoNew
Issuances
AnyholderofSeriesAPreferredShareswillhaveapreemptiverighttopurchaseuptoitsproratashare(basedonitspercentageofoutstandingOrdinarySharesonanas-if-convertedbasis)ofanysecuritiesofferedbytheCompany(subjecttocustomaryexemptions)onthesameprice,termsandconditionsastheCompanyproposestooffersuchsecuritiestootherpotentialinvestors,witharightofoversubscriptionifanyholderofSeriesAPreferredShareselectsnottopurchaseitsfullproratashare.
Information
andInspection
Rights
AnyholderofSeriesAPreferredSharesshallreceive(a)auditedannualconsolidatedfinancialstatementswithin120daysafterthefiscalyear-end,(b)unauditedquarterlyfinancialstatementswithin45daysfromfiscalquarter-end,(c)unauditedmonthlyfinancialstatementswithin30daysfromfiscalmonth-end,(d)annualbudgetandbusinessplanforthefollowingfiscalyearatleast30dayspriortothepriorfiscalyear’send,and(e)otherinformationinrelationtotheoperationandfinancialsoftheGroupCompaniesreasonably
requestedbyaholderofSeriesAPreferredShares.TheGroupCompaniesshallinformeachholderofSeriesAPreferredSharesofanyinformationthatcouldhavematerialadverseeffecttothebusiness,operation,inancial,andprospectoftheGroupCompanieswithintwodaysofreceivingsuchinformation.EachholderofSeriesAPreferredShareswillalsobegrantedwithcustomaryinspectionrightsincludingaccesstoCompanyfacilitiesandpersonnelduringnormalbusinesshoursandwithreasonableadvancenotification.
Transfer
Restrictions;
ROFR/Co-Sale
UnlessotherwiseapprovedbytheInvestor,theFoundersandotherholdersofOrdinaryShares(excludingholdersofOrdinarySharesthathavebeenconvertedfromanySeriesAPreferredShares)(the“OrdinaryShareholders”)(ifany)maynotsell,assign,transfer,pledge,hypothecate,orotherwisegrantanyinterestorrightwithrespecttoanyandalloftheirOrdinaryShares(whetherowneddirectlyorindirectlythroughaholdingentity,specialpurposevehicle,etc.)exceptforbonafideestateplanningpurposesortransfertoanotherentitywhollyownedbytheFounderspriortotheQualifiedIPO,providedthattheFoundersandotherOrdinaryShareholdersshallremaintobeboundbyrelatedagreementsandremainliableforanybreachbythepermittedtransfereeofanyprovisionunderrelatedagreementsandthepermittedtransfereeshallagreetobeboundbyrelatedagreements.
TheOrdinarySharesoftheCompany’ssecuritiesheldbytheFoundersandotherOrdinaryShareholders(ifany)aresubjecttotheholdersofSeriesAPreferredShares’rightoffirstrefusalandco-saleright(withcertaincustomaryexceptions)suchthattheFoundersandotherOrdinaryShareholdersmaynotsell,transferorexchangetheirOrdinaryShare(whetherowneddirectlyorindirectlythroughaholdingentity,specialpurposevehicle,etc.)unlesseachholderofSeriesAPreferredShareshasanopportunitytoeitherpurchasetheshares(witharightofoverallotmentifanyholderofSeriesAPreferredShareselectsnottopurchaseitsfullproratashare)onapro-ratabasis(calculatedbasedonthenumberofOrdinarySharesheldbytherelatedholdersofSeriesAPreferredSharesonanasconvertedbasis)orparticipateinthesaleonapro-ratabasis(calculatedbasedonthenumberofOrdinarySharesheldbytherelatedholdersofSeriesAPreferredSharesandthetransferringFounderorotherOrdinaryShareholdersonanasconvertedbasis).
Registration
CustomaryregistrationrightsforU.S.capitalmarket(includingnolessthan2demandregistrationrightsandunlimitedFormF-3/S-3andpiggybackregistrationrights)andsimilarrightsforothercapitalmarkets.Theregistrationrightsshallterminatedupontheearlierof(a)whenallsharesofanInvestorareeligibletobesoldwithoutrestrictionunderRule144and(b)the5thanniversaryoftheCompany’sIPO.
Employee
StockOption
Plan
ImmediatelypriortotheClosing,
%oftheCompany’sfully-dilutedsharecapitalwillbereservedforissuancepursuanttotheCompany’semployeestockoptionplantobeadoptedaftertheClo